Episodios

  • Ep 193 [29 October 2025]: Paul Petraro ScD MPH – Looking at 2030: Near future of the life science industry
    Oct 31 2025

    Ep 193 [29 October 2025]: Paul Petraro ScD MPH, Executive Director, Global Head Real World Evidence Analytics Center of Excellence at Boehringer Ingelheim – We discussed relatively near-term changes in the life science arena and impact of RWD for RWE. Please check-out our website to join the club, get updates and see podcast recordings: https://rwd-rwe.club Disclaimer: The views expressed in this podcast are the guest's and host's alone, and do not reflect the official position of any organization or entity with whom they are, or have been, professionally affiliated.

    Más Menos
    54 m
  • Ep 192 [22 October 2025]: Eric Meadows PhD – 'Trust but verify', in an AI world it's 'Trust but validate'
    Oct 25 2025

    Ep 192 [22 October 2025]: Eric Meadows PhD, Director of Scientific Engagement at Flatiron Health – We explored methods to extract data variables from real-world unstructured medical records, while ensuring the RWD is validated and ready for life science use cases. Please check-out our website to join the club, get updates and see podcast recordings: https://rwd-rwe.club Disclaimer: The views expressed in this podcast are the guest's and host's alone, and do not reflect the official position of any organization or entity with whom they are, or have been, professionally affiliated.

    Más Menos
    1 h y 1 m
  • Ep 191 [15 October 2025]: Jimmy Fisher PhD MS MBA – To AI or Not to AI: What Data Science Says About Reality
    Oct 16 2025

    Ep 191 [15 October 2025]: Jimmy Fisher PhD MS MBA who blends data science, public health, and AI to help organizations see signal in the noise. With a PhD in Epidemiology and advanced training in AI and data science, he’s spent over a decade turning real-world data (RWD) into practical, scalable solutions across the pharma and biotech world. Now stepping into a data science innovation role in consulting, Jimmy’s focus is on helping teams bridge the gap between analytics and action—where insight meets impact. Please check-out our website to join the club, get updates and see podcast recordings: https://rwd-rwe.club Disclaimer: The views expressed in this podcast are the guest's and host's alone, and do not reflect the official position of any organization or entity with whom they are, or have been, professionally affiliated.

    Más Menos
    1 h
  • Ep 190 [01 October 2025]: Jeff Morgan and Karla Feghali – RWE & GenAI: Insights from Deloitte’s 2025 Survey
    Oct 2 2025

    Ep 190 [01 October 2025]: Deloitte's Jeff Morgan and Karla Feghali – We discussed the history of RWE in our venacular and we unpacked the highlights of Deloitte’s 2025 Real-World Evidence (RWE) Benchmarking Survey. In this conversation, we’ll explored: > How are pharma leaders modernizing their RWE capabilities to support the enterprise? > What role is generative AI really playing in reshaping evidence generation — and where are the biggest hurdles? > Which capabilities and partnerships are setting top performers apart? > What’s next: How will patient-centric approaches, expanding data ecosystems, and evolving regulation shape the future of RWE? You can review the full survey here in advance: https://www.deloitte.com/content/dam/assets-zone3/us/en/docs/services/consulting/2025/ada-compliant-2025-rwe-benchmarking-report.pdf Please check-out our website to join the club, get updates and see podcast recordings: https://rwd-rwe.club Disclaimer: The views expressed in this podcast are the guest's and host's alone, and do not reflect the official position of any organization or entity with whom they are, or have been, professionally affiliated.

    Más Menos
    1 h y 4 m
  • Ep 189 [24 September 2025]: Ivana Naeymi-Rad MS – Pharma and health tech don’t lack data--they lack clarity!
    Sep 27 2025

    Ep 189 [24 September 2025]: Ivana Naeymi-Rad MS, COO at IMO Health – Pharma and health tech companies don’t suffer from a lack of data; they suffer from a lack of clarity as clinical insights are buried under billing codes, unstructured notes, and inconsistent language that distort intent. Manual reviews and mapping struggle to keep pace, leading to gaps, noise, and lost reproducibility and endpoints. Ivana shared why normalization and IMO Health’s terminology is the essential companion to all real-world data, ensuring clinical intent is preserved, transforming costly RWD investments into insights and evidence you can trust. Please check-out our website to join the club, get updates and see podcast recordings: https://rwd-rwe.club Disclaimer: The views expressed in this podcast are the guest's and host's alone, and do not reflect the official position of any organization or entity with whom they are, or have been, professionally affiliated.

    Más Menos
    1 h y 3 m
  • Ep 187 [10 September 2025]: Special collaborative Real World Wednesday with the with the RWEsearch Annual Summit 2025 (hosted by Healthark Insight) that was conducted live: Application of RWD for RWE.
    Sep 19 2025

    Ep 187 [10 September 2025]: Special collaborative Real World Wednesday with the with the RWEsearch Annual Summit 2025 (hosted by Healthark Insight) that was conducted live on 10 September 2025 with Charlie Barr MD MPH, Stuart McCully PhD, and Radek Wasiak PhD: Conceptualize, Realize and Operationalize: Application of RWD for RWE. - Charlie Barr MD MPH, Managing Director & Founder of Pivotal Strategic Consulting, Chief Medical Officer at Adaptic Health - Stuart McCully PhD, CEO & Co-founder of RWRegs - Radek Wasiak PhD, CEO & Co-founder of rAIRe(TM), Director & Co-founder of Adigens Health Please check-out our website to join the club, get updates and see podcast recordings: https://rwd-rwe.club Disclaimer: The views expressed in this podcast are the guest's and host's alone, and do not reflect the official position of any organization or entity with whom they are, or have been, professionally affiliated.

    Más Menos
    1 h y 59 m
  • Ep 188 [17 September 2025]: Melanie Philofsky – RWW: Why RWD standardization matters
    Sep 17 2025

    Ep 188 [17 September 2025]: Melanie Philofsky, a former nurse and currently Director of Clinical Informatics that leads the RWD consulting group at EPAM Systems – We discussed why RWD standardization matters, including the harmonization of disparate healthcare data sources into the OMOP Common Data Model to support research and operational analytics, with expertise in health systems, clinical informatics, data analysis, data quality and data modeling. Please check-out our website to join the club, get updates and see podcast recordings: https://rwd-rwe.club Disclaimer: The views expressed in this podcast are the guest's and host's alone, and do not reflect the official position of any organization or entity with whom they are, or have been, professionally affiliated.

    Más Menos
    1 h
  • Ep 185 [30 July 2025]: Ewa Kleczyk PhD – Linked RWD: Half the Data, Half the Truth
    Aug 5 2025

    Ep 185 [30 July 2025]: Ewa Kleczyk PhD, SVP of Operations at Target RWE – We explored deeper RWD curation through linking and this curated dataset’s relevance in evaluation of rare conditions, with extrapolation to under-represented and broadly accessible patient populations alike. Please check-out our website to join the club, get updates and see podcast recordings: https://rwd-rwe.club Disclaimer: The views expressed in this podcast are the guest's and host's alone, and do not reflect the official position of any organization or entity with whom they are, or have been, professionally affiliated.

    Más Menos
    1 h y 1 m